| Original language | English (US) |
|---|---|
| Pages (from-to) | 558-559 |
| Number of pages | 2 |
| Journal | Vascular Medicine (United Kingdom) |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1 2018 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Centers for Medicare & Medicaid Services’ decision on drug-coated balloons : No additional reimbursement despite higher cost and highest levels of scientific evidence. / Shishehbor, Mehdi H.; White, Christopher J.; Beckman, Joshua A. et al.
In: Vascular Medicine (United Kingdom), Vol. 23, No. 6, 01.12.2018, p. 558-559.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Centers for Medicare & Medicaid Services’ decision on drug-coated balloons
T2 - No additional reimbursement despite higher cost and highest levels of scientific evidence
AU - Shishehbor, Mehdi H.
AU - White, Christopher J.
AU - Beckman, Joshua A.
AU - Misra, Sanjay
AU - Schneider, Peter A.
AU - Lookstein, Robert A.
AU - Kashyap, Vikram S.
AU - Clair, Daniel
AU - Jones, W. Schuyler
AU - Rosenfield, Kenneth
AU - Katzen, Barry T.
AU - Jaff, Michael R.
N1 - Funding Information: AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi; Data Safety Monitoring Board (DSMB): Bayer; Ownership: EMX, Jana Care; Board: Vascular Interventional Advances (VIVA). Sanjay Misra – NIH R01 grants (HL098967 and DK 107870), research grants from Boeringer Ingelheim; DSMB Chair: CORDIS. Peter A Schneider – Modest royalty for intellectual property: Cook Medical; Chief Medical Officer, Co-Founder: Cagent Vascular, Intact Vascular; Scientific Advisory Board: Medtronic, Boston Scientific, Abbott Vascular; Consultant: SurModics, Silk Road Medical. Robert A Lookstein – Consultant and Advisory Board: Boston Scientific, Medtronic. Vikram S Kashyap – None. Daniel Clair – Consultant: Boston Scientific, Endologix, Medtronic, Shockwave Medical. W Schuyler Jones – Consultant/Honoraria: Janssen Pharmaceuticals, Bayer, Bristol-Myers Squibb, Pfizer (all small, < $10k); Research Grants: Agency for Healthcare Research and Quality, Doris Duke Charitable Foundation, Medtronic, Patient-Centered Outcomes Research Institute. Kenneth Rosenfield – Consultant: Abbott Vascular, Cardinal Health, InspireMD, Shockwave, SurModics, Philips-Volcano; Equity: Contego, Micell Technologies; Research Support: NIH; Board Member: VIVA Physicians. Barry T Katzen – Scientific Advisory Board: Boston Scientific, WL Gore, Philips Healthcare, GraftWorx. Michael R Jaff – Uncompensated advisor: Abbott, Boston Scientific, Cordis, a Cardinal Health company, Medtronic; Consultant: Micell Technologies, Philips-Volcano, Venarum Medical, Vactronix Scientific; Equity Investor: Embolitech, Gemini, PQ Bypass, Primacea, Vascular Therapies, Sano V.
PY - 2018/12/1
Y1 - 2018/12/1
UR - http://www.scopus.com/inward/record.url?scp=85058117982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058117982&partnerID=8YFLogxK
U2 - 10.1177/1358863X18802969
DO - 10.1177/1358863X18802969
M3 - Editorial
C2 - 30238852
AN - SCOPUS:85058117982
SN - 1358-863X
VL - 23
SP - 558
EP - 559
JO - Vascular Medicine (United Kingdom)
JF - Vascular Medicine (United Kingdom)
IS - 6
ER -